153 related articles for article (PubMed ID: 37132128)
1. Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review.
Wilkie BD; Noori J; Johnston M; Woods R; Keck JO; Behrenbruch C
ANZ J Surg; 2023 Sep; 93(9):2086-2091. PubMed ID: 37132128
[TBL] [Abstract][Full Text] [Related]
2. The Use of Pyridostigmine in a Child With Chronic Intestinal Pseudo-Obstruction.
Choudhury A; Rahyead A; Kammermeier J; Mutalib M
Pediatrics; 2018 Apr; 141(Suppl 5):S404-S407. PubMed ID: 29610160
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine.
O'Dea CJ; Brookes JH; Wattchow DA
Colorectal Dis; 2010 Jun; 12(6):540-8. PubMed ID: 19508545
[TBL] [Abstract][Full Text] [Related]
4. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series.
Manini ML; Camilleri M; Grothe R; Di Lorenzo C
Paediatr Drugs; 2018 Apr; 20(2):173-180. PubMed ID: 29243034
[TBL] [Abstract][Full Text] [Related]
5. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls.
Menys A; Butt S; Emmanuel A; Plumb AA; Fikree A; Knowles C; Atkinson D; Zarate N; Halligan S; Taylor SA
Neurogastroenterol Motil; 2016 Mar; 28(3):376-83. PubMed ID: 26661570
[TBL] [Abstract][Full Text] [Related]
6. Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review.
Di Nardo G; Viscogliosi F; Esposito F; Stanghellini V; Villa MP; Parisi P; Morlando A; Caló G; De Giorgio R
J Neurogastroenterol Motil; 2019 Oct; 25(4):508-514. PubMed ID: 31587541
[TBL] [Abstract][Full Text] [Related]
7. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI.
Ohkubo H; Kessoku T; Fuyuki A; Iida H; Inamori M; Fujii T; Kawamura H; Hata Y; Manabe N; Chiba T; Kwee TC; Haruma K; Matsuhashi N; Nakajima A; Takahara T
Am J Gastroenterol; 2013 Jul; 108(7):1130-9. PubMed ID: 23511458
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.
Bharucha AE; Low PA; Camilleri M; Burton D; Gehrking TL; Zinsmeister AR
Clin Auton Res; 2008 Aug; 18(4):194-202. PubMed ID: 18622640
[TBL] [Abstract][Full Text] [Related]
9. Small intestine motility disorders: Chronic intestinal pseudo-obstruction.
Billiauws L; Cohen M; Cazals-Hatem D; Joly F
J Visc Surg; 2022 Mar; 159(1S):S22-S27. PubMed ID: 35131150
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic pseudo-obstruction: a current update.
Bernardi MP; Warrier S; Lynch AC; Heriot AG
ANZ J Surg; 2015 Oct; 85(10):709-14. PubMed ID: 25943300
[TBL] [Abstract][Full Text] [Related]
12. Chronic intestinal pseudo-obstruction.
Sadjadpour K
Mayo Clin Proc; 1989 Jun; 64(6):728. PubMed ID: 2747296
[No Abstract] [Full Text] [Related]
13. An international survey on clinicians' perspectives on the diagnosis and management of chronic intestinal pseudo-obstruction and enteric dysmotility.
Vasant DH; Pironi L; Barbara G; Bozzetti F; Cuerda C; Joly F; Mundi M; Paine P; Staun M; Szczepanek K; Van Gossum A; Wanten G; Lal S
Neurogastroenterol Motil; 2020 Dec; 32(12):e13937. PubMed ID: 32696607
[TBL] [Abstract][Full Text] [Related]
14. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
[TBL] [Abstract][Full Text] [Related]
15. Dysmotility disorders: a nutritional approach.
Billiauws L; Corcos O; Joly F
Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):483-8. PubMed ID: 25023191
[TBL] [Abstract][Full Text] [Related]
16. The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.
Robinson-Papp J; Nmashie A; Pedowitz E; George MC; Sharma S; Murray J; Benn EKT; Lawrence SA; Machac J; Heiba S; Kim-Schulze S; Navis A; Roland BC; Morgello S
J Neurovirol; 2019 Aug; 25(4):551-559. PubMed ID: 31098925
[TBL] [Abstract][Full Text] [Related]
17. The chronic intestinal pseudo-obstruction subtype has prognostic significance in patients with severe gastrointestinal dysmotility related intestinal failure.
Vasant DH; Kalaiselvan R; Ablett J; Bond A; Abraham A; Teubner A; Green D; Paine PA; Lal S
Clin Nutr; 2018 Dec; 37(6 Pt A):1967-1975. PubMed ID: 30290972
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction: a retrospective study of 33 patients.
Fuyuki A; Ohkubo H; Higurashi T; Iida H; Inoh Y; Inamori M; Nakajima A
J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 27549243
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction.
Downes TJ; Cheruvu MS; Karunaratne TB; De Giorgio R; Farmer AD
J Clin Gastroenterol; 2018 Jul; 52(6):477-489. PubMed ID: 29877952
[TBL] [Abstract][Full Text] [Related]
20. Prokinetics in the treatment of acute intestinal pseudo-obstruction.
De Giorgio R; Stanghellini V; Barbara G; Guerrini S; Lioce A; Vasina V; Tonini M; Cola B; Corinaldesi R; De Ponti F
IDrugs; 2004 Feb; 7(2):160-5. PubMed ID: 15057661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
